[Minimally Invasive Surgery in Thymic Malignances]

Zhongguo Fei Ai Za Zhi. 2018 Apr 20;21(4):269-272. doi: 10.3779/j.issn.1009-3419.2018.04.06.
[Article in Chinese]

Abstract

Surgery is the most important therapy for thymic malignances. The last decade has seen increasing adoption of minimally invasive surgery (MIS) for thymectomy. MIS for early stage thymoma patients has been shown to yield similar oncological results while being helpful in minimize surgical trauma, improving postoperative recovery, and reduce incisional pain. Meanwhile, With the advance in surgical techniques, the patients with locally advanced thymic tumors, preoperative induction therapies or recurrent diseases, may also benefit from MIS in selected cases.

手术是胸腺肿瘤最重要的治疗方式。近年来,胸腺肿瘤的微创手术在国内外获得迅速推广。微创手术目前主要用于早期胸腺肿瘤的外科治疗,已有证据表明,微创手术可有效减少手术创伤、有效加快患者的术后恢复以及降低术后疼痛,并且目前已有一定临床证据初步证实其肿瘤学效果与开放手术相当。同时随着外科技术的不断进步,在保证外科学和肿瘤学原则的前提下,微创手术有可能使包括局部进展期、诱导治疗后以及复发转移的患者从中获益。.

Keywords: Minimally invasive surgery; Thymic malignance; Video-assisted thoracoscopic surgery.

MeSH terms

  • Humans
  • Minimally Invasive Surgical Procedures / methods
  • Minimally Invasive Surgical Procedures / trends*
  • Retrospective Studies
  • Thymoma / surgery
  • Thymus Neoplasms / mortality
  • Thymus Neoplasms / pathology
  • Thymus Neoplasms / surgery*